/Companies

HedgePath Pharmaceuticals

OTC: INTI

Tampa, US · Delaware corporation · 1 known investors

Find your way into HedgePath Pharmaceuticals

Sign up to see every warm intro you have to HedgePath Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the HedgePath Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

FEFrank E. O'Donnell, Jr., MD
Frank E. O'Donnell, Jr., MDExecutive
NJ
Nicholas J. VircaExecutive
GH
Garrison Hasara, CPAExecutive
FEFrancis E. O'Donnell
Francis E. O'DonnellExecutive Chairman of the Board and Chief Executive Officer
JA
James A. McNultyInterim Chief Financial Officer, Treasurer and SecretaryTreasurer, Chief Financial Officer and Secretary at Telomir Pharmaceuticals

Board

SJ
Stefan J. CrossBoard director
SP
Samuel P. Sears, Jr.Board director
RD
R. Dana Ono, MDBoard director
WM
W. Mark Watson, CPABoard director

Investors · 1

Also in the syndicate · 1

Mayne Pharma

Reported raises · per SEC filings

Form D private placements

$600K disclosed across 1 of 3 rounds · 2014–2018

▶$600KraisedApr 2016 · 3 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Samuel P. Sears, Jr.Director
  • R. Dana Ono, MDDirector
  • Frank E. O'Donnell, Jr., MDExecutive Officer, Director
  • Nicholas J. VircaExecutive Officer
  • W. Mark Watson, CPADirector
  • Garrison Hasara, CPAExecutive Officer
  • Stefan J. CrossDirector
Offering amount
$5.5M
Amount sold
$600K
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has HedgePath Pharmaceuticals raised?
HedgePath Pharmaceuticals has disclosed $600K raised across 1 of its 3 known rounds.
Where is HedgePath Pharmaceuticals headquartered?
HedgePath Pharmaceuticals is headquartered in Tampa, US.